BractonDeal Intel
Get full access
AcquisitionOther

Zymeworks Inc. acquired Theravance Biopharma.

Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.

Deal tape row

Zymeworks Inc. -> Theravance Biopharma.

Zymeworks is a global biotechnology company building a diversified portfolio of healthcare assets designed to generate durable cash flows while advancing innovative medicines for difficult-to-treat diseases.

Open source record (SEC) ↗
Bracton Partners

Sell-side M&A advisory for software, fintech and data companies. Everything on these pages is built from primary sources: SEC filings, company announcements, and the public record. No estimates and no unnamed sources.

bractonpartners.comApproachForm D monitorDisclosures

M&A advisory only. No capital-raising services are offered. Nothing on this page is a valuation, a recommendation, or an offer of any security.